Recent WHO reports identify Mycobacterium tuberculosis (Mtb) as the single largest cause of death of individuals infected with the Human Immunodeficiency Virus (HIV), a co-infection state highly prevalent in Sub- Saharan Africa. Susceptibility to TB infection appears to be more complex than loss of surveillance through depletion of CD4+ T-cells. In preliminary experiments we show that replication of Mtb in macrophages is enhanced by co-infection with HIV. We propose extensive cellular and molecular analyses of experimental co- infections to be performed at Cornell University, Ithaca, NY. In addition, we have an HIV study cohort at the Queen Elizabeth Central Hospital (QECH) in Blantyre, Malawi and will probe the relevance of in vitro phenotypes through analysis of macrophages and lymphocytes from the lungs of HIV-infected individuals. This current study is founded on the hypothesis HIV infection of alveolar macrophages plays a significant role in the increased susceptibility to development of active tuberculosis.
Specific Aim #1. How does HIV infection promote the intracellular growth of Mtb? A. What causes the increased permissiveness of the host cell? To elucidate the mechanism(s) by which HIV infection promotes bacterial survival we are targeting the following 3 questions: i. Is the Mtb growth advantage restricted to HIV infected cells? ii. Does HIV infection modulate the microbicidal activities of the macrophage? iii. What HIV ORFs mediate this alteration in the macrophage environment? B. How does Mtb exploit this increased permissiveness? We propose both biased and unbiased genetic screens to identify genes required for enhanced Mtb growth in HIV-infected HMDM. i. Biased approach based on the hypothesis that the altered lipid metabolism favors bacterial replication. ii. Unbiased Transposon-insertion site mapping (TraSH) screen of Mtb in HIV-infected macrophages.
Specific Aim #2. How does HIV impact the immune environment of the lung to render it more permissive to infection and/or progression of tuberculosis? We will assess the capacity of HIV to render AM more permissive to infection by Mtb. A. Utilization of HMDMs as surrogates for the development of a Mtb survival assay B. How is the functional phenotype of human alveolar macrophage modulated in the context of HIV infection?

Public Health Relevance

HIV is the major risk factor for the development of tuberculosis, and tuberculosis is the commonest disease to emerge on progression to AIDS in Sub-Saharan Africa. The altered immune environment in the lung that favors the emergence of tuberculosis appears to be more than just the loss of CD4+ T-cells. We propose an in depth analysis of this co-infection in both defined tissue culture models and in cells from the lungs of HIV- infected individuals to determine how HIV impacts the immune environment of the lung to render alveolar macrophages more permissive to Mtb.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI118582-05
Application #
9707723
Study Section
AIDS-associated Opportunistic Infections and Cancer Study Section (AOIC)
Program Officer
Frank, Daniel J
Project Start
2015-06-15
Project End
2021-05-31
Budget Start
2019-06-01
Budget End
2021-05-31
Support Year
5
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Cornell University
Department
Microbiology/Immun/Virology
Type
Schools of Veterinary Medicine
DUNS #
872612445
City
Ithaca
State
NY
Country
United States
Zip Code
14850
Huang, Lu; Kushner, Nicole L; Theriault, Monique E et al. (2018) The Deconstructed Granuloma: A Complex High-Throughput Drug Screening Platform for the Discovery of Host-Directed Therapeutics Against Tuberculosis. Front Cell Infect Microbiol 8:275
Xu, Yitian; Huang, Lu; Kirschman, Jonathan L et al. (2018) Exploitation of Synthetic mRNA To Drive Immune Effector Cell Recruitment and Functional Reprogramming In Vivo. J Immunol :
Huang, Lu; Nazarova, Evgeniya V; Tan, Shumin et al. (2018) Growth of Mycobacterium tuberculosis in vivo segregates with host macrophage metabolism and ontogeny. J Exp Med 215:1135-1152
Nazarova, Evgeniya V; Montague, Christine R; La, Thuy et al. (2017) Rv3723/LucA coordinates fatty acid and cholesterol uptake in Mycobacterium tuberculosis. Elife 6:
Tan, Shumin; Yates, Robin M; Russell, David G (2017) Mycobacterium tuberculosis: Readouts of Bacterial Fitness and the Environment Within the Phagosome. Methods Mol Biol 1519:333-347
Huang, Lu; Russell, David G (2017) Protective immunity against tuberculosis: what does it look like and how do we find it? Curr Opin Immunol 48:44-50
Nazarova, Evgeniya V; Russell, David G (2017) Growing and Handling of Mycobacterium tuberculosis for Macrophage Infection Assays. Methods Mol Biol 1519:325-331
Jambo, Kondwani C; Tembo, Dumizulu L; Kamng'ona, Arox W et al. (2017) HIV-associated disruption of lung cytokine networks is incompletely restored in asymptomatic HIV-infected Malawian adults on antiretroviral therapy. ERJ Open Res 3:
Gupta-Wright, Ankur; Tembo, Dumizulu; Jambo, Kondwani C et al. (2017) Functional Analysis of Phagocyte Activity in Whole Blood from HIV/Tuberculosis-Infected Individuals Using a Novel Flow Cytometry-Based Assay. Front Immunol 8:1222
VanderVen, Brian C; Huang, Lu; Rohde, Kyle H et al. (2016) The Minimal Unit of Infection: Mycobacterium tuberculosis in the Macrophage. Microbiol Spectr 4:

Showing the most recent 10 out of 13 publications